A5065373209- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Structural Anomalies and Repair
- Cardiovascular Function and Risk Factors
- Aortic Disease and Treatment Approaches
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Congenital Heart Disease Studies
- Pulmonary Hypertension Research and Treatments
- Coronary Interventions and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac tumors and thrombi
- Reconstructive Surgery and Microvascular Techniques
- Heart Failure Treatment and Management
- Fluid Dynamics and Thin Films
- Pain Management and Treatment
- Cardiomyopathy and Myosin Studies
- Mechanical Circulatory Support Devices
- Cardiac Arrhythmias and Treatments
- Hydraulic and Pneumatic Systems
- Digital Marketing and Social Media
- Metabolism and Genetic Disorders
- Acute Myocardial Infarction Research
- Pericarditis and Cardiac Tamponade
- Atrial Fibrillation Management and Outcomes
Istituti di Ricovero e Cura a Carattere Scientifico
2020-2025
Vita-Salute San Raffaele University
2020-2025
Johannes Gutenberg University Mainz
2024-2025
San Raffaele University of Rome
2024
Valve (United States)
2024
Mylan (South Africa)
2024
Fondazione Toscana Gabriele Monasterio
2023-2024
Guy's Hospital
2024
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2020-2024
Maastricht University
2024
This study aimed at assessing mid-term outcomes of patients undergoing isolated tricuspid valve (TV) surgery based on a preoperative baseline clinical and functional classification.All treated with TV repair or replacement from March 1997 to May 2020 single institution were retrospectively reviewed assessed for postoperative outcome according novel classification [stages 1-5 related the absence presence extent right heart failure (RHF)]. Kaplan-Meier survival curves used estimate survival....
Background and Objectives: Acute type A aortic dissection (AAD) is a life-threatening disease. No differences between men women have been made in the treatment of AAD so far knowledge about sex regarding long-term outcomes limited. Materials Methods: Between 01/2004 12/2021, 874 patients were operated on for AAD, including 313 (35.8%) 561 (64.2%) men. Clinical surgical records, follow-up information, obtained analyzed retrospectively. To account outcome determined by different preoperative...
The COAPT Trial was the first ever to demonstrate a survival benefit in treating functional mitral regurgitation (FMR). That achieved through transcatheter repair selected patients. exact proportion of patients fulfilling selection criteria real-world is unknown.
Abstract OBJECTIVES The aim of this study was to assess the long-term outcomes different surgical strategies in patients with hypertrophic obstructive cardiomyopathy (HOCM) septal thickness ≤18 mm and systolic anterior motion (SAM)-related moderate-to-severe mitral regurgitation (MR). METHODS Seventy-six HOCM 17 [16; 18] mm, resting left ventricle outflow tract gradient 60 [41; 85] mmHg SAM-related MR ≥2+/4+, underwent myectomy alone (54%) or valve (MV) surgery ± (46%). RESULTS No hospital...
We describe long-term clinical and echocardiographic outcomes in the largest single-centre cohort of patients who underwent aortic valve replacement (AVR) with sutureless Perceval (CorCym, Italy) bioprosthesis.Between March 2011 2021, 1157 AVR bioprosthesis implantation. Mean age was 77 ± 6 years (range: 46-89 years) mean EuroSCORE II 6.7 3.2% 1.7-14.2%). Concomitant procedures were performed 266 (23%).Thirty-day mortality 1.38% (16/1157). Eight hundred twenty 891 (92%) isolated AVRs...
ABSTRACT Background The COAPT Trial was the first ever to demonstrate a survival benefit in treating functional mitral regurgitation (FMR). That achieved through transcatheter repair selected patient. exact proportion of patients fulfilling selection criteria real-world is unknown. Objectives assess applicability and its impact on patients’ survival. Methods We assessed clinical data follow-up results all consecutive admitted for FMR at our Department between January 2016 May 2021 according...
A 66-year-old woman with a complex medical history underwent transcatheter mitral valve replacement (TMVI) owing to insufficiency. Risk factors and noncompliance led bioprosthetic thrombosis (BPVT) within 3 years. Emergent surgery indicated by an ad hoc heart team successfully managed the situation, showcasing challenges in BPVT management after TMVI.
Tricuspid regurgitation (TR) is associated with heart failure (HF) and reduced survival. Within a short-time period, transcatheter tricuspid valve repair or replacement (TTVR/TTVr) for TR has evolved from innovation to clinical reality. The present study's aim provide 1-year results between patients treated TTVR TTVr compared untreated patients, in terms of cardiac survival, rehospitalization, right-side HF symptom development, New York Heart Association (NYHA) improvement.
The TRI-SCORE is a recently published risk score for predicting in-hospital mortality in patients undergoing isolated tricuspid valve surgery (ITVS). aim of this study to externally validate the ability and long-term following ITVS.A retrospective review our institutional database was carried out identify all repair or replacement from March 1997 2021. calculated patients. Discrimination assessed using receiver operating characteristic curves. Accuracy models tested calculating Brier score....
Mitral regurgitation (MR) due to commissural prolapse or flail represents a pattern of valve dysfunction that can be treated, among other techniques, by suturing the margins anterior and posterior leaflets in area (commissural closure). The very long-term results this technique have not been reported so far represent objective study.A retrospective review our institutional database was carried on querying for patients who underwent closure ring annuloplasty within time frame 1997-2007...
Abstract OBJECTIVES 3-Dimensional (3D)-shaped rings are largely adopted for tricuspid annuloplasty, but evidence about their long-term results is scanty. The goal of this study was to analyse the annuloplasty with 3D-shaped rings. MATERIALS AND METHODS A retrospective review our prospectively maintained database carried out identify all patients who underwent valve repair between January 2011 and December 2014. Kaplan–Meier methods were used survival. Cumulative incidence function using...
With the expanding use of cardiac implantable electronic devices (CIEDs), lead interference with tricuspid valve (TV) causing significant regurgitation (TR) has gained increasing recognition. However, current knowledge about long-term results surgical treatment TR in this setting is scanty. Therefore, information was goal study.A retrospective review our institutional database carried out to select all patients previously implanted CIEDs who underwent repair and replacement from 2000 through...
Abstract OBJECTIVES After mitral repair for degenerative regurgitation (MR), no or mild (≤1+/4+) residual MR should remain. Occasionally patients are left with more than (>1+/4+) a number of reasons. The aim this study was to assess the late implications such suboptimal in matched cohort study. METHODS From 2006 2013, total 2158 underwent our institution. Fifty (2.3%) >1+ at hospital discharge (study group) were up 1:2 91 operated on during same period who discharged ≤1+...
Abstract Background/Introduction Transcatheter mitral valve replacement (TMVR) is emerging in recent years as a promising tool to treat regurgitation, however its applicability the real world remains limited. Purpose The aim of study assess real-world screening success rate TMVR native anatomy and 1-year outcomes both accepted refused patients well clinical results. Methods Retrospective analysis was performed on all screened for at our Valve Center, eligible follow-up. In-hospital data...